What is Precigen's cash & equivalents?

Precigen (PGEN) reported cash & equivalents of $7.48M in Q1 2026.

How has Precigen's cash & equivalents changed year-over-year?

Precigen's cash & equivalents increased by 23.5% year-over-year, from $6.06M to $7.48M.

What is the long-term trend for Precigen's cash & equivalents?

Over 5 years (2020 to 2025), Precigen's cash & equivalents has grown at a -10.4% compound annual growth rate (CAGR), from $52.25M to $30.23M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Precigen PGEN Cash & Equivalents

Cash & Equivalents at other companies

Bristol-Myers SquibbBMY

$9.57B-12.0%

Regeneron PharmaceuticalsREGN

$2.97B-4.0%

Gilead SciencesGILD

$7.63B-3.8%

Viridian Therapeutics, Inc.VRDN

$176.35M+51.7%

Agios PharmaceuticalsAGIO

$113.6M+43.9%

Apogee Therapeutics, Inc.APGE

$451.8M+323%

Other financials

Income statement

See full

Revenue$23.3M+1,634%

Operating income-$6.0M+73.5%

Net income-$7.9M+85.4%

EPS (diluted)-$0.02+88.9%

Balance sheet

See full

Total debt$98.3M+1,714%

Total equity$20.2M+244%

Total assets$138.6M+7.6%

Cash flow

See full

Operating cash flow-$43.8M-168%

CapEx$258.0K-58.5%

Free cash flow-$44.1M-160%

Valuation

See full

Market cap$1.91B+213%

Enterprise value$2B+234%

P/S72×—

Profitability

See full

Gross margin83.6%—

Operating margin-2,890.9%—

Net margin-3,656%—

FCF margin-1,756.5%—

Returns & leverage

See full

Return on equity-843.6%-1,103pp

Debt / equity4.9×—

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Precigen's cash & equivalents?: Precigen (PGEN) reported cash & equivalents of $7.48M in Q1 2026.
How has Precigen's cash & equivalents changed year-over-year?: Precigen's cash & equivalents increased by 23.5% year-over-year, from $6.06M to $7.48M.
What is the long-term trend for Precigen's cash & equivalents?: Over 5 years (2020 to 2025), Precigen's cash & equivalents has grown at a -10.4% compound annual growth rate (CAGR), from $52.25M to $30.23M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.